Scientific Session
Antiphospholipid Syndrome
Doruk Erkan, MD, MPH
Hospital for Special Surgery
New York, NY, United States
Disclosure: Disclosure(s): ACR/EULAR: Grant/Research Support (Ongoing); Aurinia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Consultant (Ongoing); Exagen: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lupus Clinical Trials Consortium: Grant/Research Support (Ongoing); NIH-NIAID: Grant/Research Support (Ongoing); Up-To-Date: Royalties (Ongoing)